Blue Trust Inc’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Blue Trust Inc’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-65	Closed	-$10K	–	2760
2022 Q4	$10K	Buy	+65	New	+$9.87K	﹤0.01%	1550
2022 Q3	–	Sell	-2	Closed	–	–	2435
2022 Q2	$0	Buy	+2	New	+$255	﹤0.01%	2063

Other funds holding BHVN

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

LIP

Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Blue Trust Inc's BHVN Position: Q1 2023 in Review

Blue Trust Inc sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2023, closing a stake of 65 shares — an estimated $10K sold.

Blue Trust Inc first reported a position in BHVN in Q2 2022 and held it in 2 quarters. The position peaked at $10K in Q4 2022. 2 funds tracked by Wall St. Rank hold BHVN as of Q1 2023.

Blue Trust Inc reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2023 after selling out during the quarter.
Blue Trust Inc sold 65 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2023, an estimated $10K.
Blue Trust Inc first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022 and held it in 2 quarters.
Blue Trust Inc's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10K in Q4 2022.
2 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2023.

Based on Blue Trust Inc's 13F filing for Q1 2023, filed 17 Apr 2023.